Carmel B. Nanthakumar

1.6k citations

15 papers · 932 indexed · 1 hit paper · h-index 10

Co-authors: Richard P. Marshall Gísli Jenkins Richard J. D. Hatley Simon J. F. Macdonald Jack Gauldie Rachel C. Chambers Geoffrey J. Laurent Robin J. McAnulty
Topics: Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (11 papers)Inhalation and Respiratory Drug Delivery (4 papers)Occupational exposure and asthma (3 papers)
Cited by: Pulmonary and Respiratory Medicine Immunology and Allergy Hepatology
Journals: SHILAP Revista de lepidopterologíaNature Reviews Drug Discovery American Journal Of Pathology
Partner nations: United Kingdom Denmark United States

In The Last Decade

Carmel B. Nanthakumar

14 papers receiving 923 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

An Official American Thoracic Society Workshop Report: Use of Animal Models for the Preclinical Assessment of Potential Therapies for Pulmonary Fibrosis

2017 280 citations Gísli Jenkins, Bethany B. Moore et al. American Journal of Respiratory Cell and Molecular Biology profile →

Peers

Countries citing papers authored by Carmel B. Nanthakumar

Since Specialization

Citations

This map shows the geographic impact of Carmel B. Nanthakumar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carmel B. Nanthakumar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carmel B. Nanthakumar more than expected).

Fields of papers citing papers by Carmel B. Nanthakumar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carmel B. Nanthakumar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carmel B. Nanthakumar. The network helps show where Carmel B. Nanthakumar may publish in the future.

Co-authorship network of co-authors of Carmel B. Nanthakumar

This figure shows the co-authorship network connecting the top 25 collaborators of Carmel B. Nanthakumar. A scholar is included among the top collaborators of Carmel B. Nanthakumar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carmel B. Nanthakumar. Carmel B. Nanthakumar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

#	Work	Indexed citations
1	Comorbidity profiles in chronic obstructive pulmonary disease: a multicohort study 2025 ·ERJ Open Research ·(unknown),(unknown),M.A. Karsdal,Diana Julie Leeming,Carmel B. Nanthakumar,Julie Yates,Dirk‐Jan Slebos,Simon D. Pouwels,Jorine E. Hartman,Jannie Marie Bülow Sand	0
2	Transglutaminase 2: a novel therapeutic target for idiopathic pulmonary fibrosis using selective small molecule inhibitors 2021 ·Amino Acids ·(unknown),Zejing Wang,Andy Blanchard,Carmel B. Nanthakumar,Martin Griffin	25
3	An integrated multiomic and quantitative label-free microscopy-based approach to study pro-fibrotic signalling in ex vivo human precision-cut lung slices 2020 ·European Respiratory Journal ·Muzamil Majid Khan,Daniel Poeckel,Aliaksandr Halavatyi,(unknown),Frank Stein,Johanna Vappiani,Daniel C. Sévin,Christian Tischer,Nico Zinn,Jessica Eley,N.S. Gudmann,Thomas Muley,H. Winter,Andrew J. Fisher,Carmel B. Nanthakumar,Giovanna Bergamini,Rainer Pepperkok	25
4	Prolonged Scar-in-a-Jar: an in vitro screening tool for anti-fibrotic therapies using biomarkers of extracellular matrix synthesis 2020 ·Respiratory Research ·Sarah Rank Rønnow,(unknown),Federica Genovese,Carmel B. Nanthakumar,(unknown),Robert B. Good,Sarah Brockbank,Simon Cruwys,(unknown),Grith Lykke Sørensen,M.A. Karsdal,Diana Julie Leeming,Jannie Marie Bülow Sand	29
5	Biomarkers of collagen synthesis predict progression in the PROFILE idiopathic pulmonary fibrosis cohort 2019 ·Respiratory Research ·Louise Organ,(unknown),Eunice Oballa,(unknown),Juliet K. Simpson,Arthur R Kang’ombe,Rebecca Braybrooke,Philip L. Molyneaux,Bernard V. North,(unknown),Diana Julie Leeming,M.A. Karsdal,Carmel B. Nanthakumar,William A. Fahy,Richard P. Marshall,Gísli Jenkins,Toby M. Maher	88
6	Single-Step, High-Efficiency CRISPR-Cas9 Genome Editing in Primary Human Disease-Derived Fibroblasts 2019 ·The CRISPR Journal ·(unknown),Robert B. Good,Radu Rapiteanu,Tobias Schmidt,(unknown),(unknown),Maria I. New,Carmel B. Nanthakumar,Joanna Betts,Andy Blanchard,Klio Maratou	18
7	A high content, phenotypic ‘scar-in-a-jar’ assay for rapid quantification of collagen fibrillogenesis using disease-derived pulmonary fibroblasts 2019 ·SHILAP Revista de lepidopterología ·Robert B. Good,Jessica Eley,Elaine Gower,(unknown),Andrew D. Blanchard,Andrew J. Fisher,Carmel B. Nanthakumar	20
8	Omipalasib Modulates Extracellular Matrix Turnover in IPF Patients: Exploratory Biomarker Analysis from a Phase I Proof of Mechanism Study 2019 ·Carmel B. Nanthakumar,Jessica Eley,Yim Man,N.S. Gudmann,Rachel C. Chambers,Andy Blanchard,William A. Fahy,Toby M. Maher	5
9	An Official American Thoracic Society Workshop Report: Use of Animal Models for the Preclinical Assessment of Potential Therapies for Pulmonary Fibrosisbreakdown → 2017 ·American Journal of Respiratory Cell and Molecular Biology ·Gísli Jenkins,Bethany B. Moore,Rachel C. Chambers,Oliver Eickelberg,Mélanie Königshoff,Martin Kolb,Geoffrey J. Laurent,Carmel B. Nanthakumar,Mitchell A. Olman,Annie Pardo,Moisés Selman,Dean Sheppard,Patricia J. Sime,Andrew M. Tager,Amanda L. Tatler,Victor J. Thannickal,Eric S. White	280
10	Exploration of a potent PI3 kinase/mTOR inhibitor as a novel anti-fibrotic agent in IPF 2016 ·Thorax ·Paul F. Mercer,Hannah V. Woodcock,Jessica Eley,Manuela Platé,Michal Sulikowski,Pascal F. Durrenberger,Linda A. Franklin,Carmel B. Nanthakumar,Yim Man,Federica Genovese,Robin J. McAnulty,Shuying Yang,Toby M. Maher,Andrew G. Nicholson,Andy Blanchard,Richard P. Marshall,Pauline T. Lukey,Rachel C. Chambers	154
11	P109 <break /> High Affinity Engagement of the αvβ6 Integrin Induces Degradation: A Novel Mechanism for Sustained Inhibition of Pro-Fibrotic TGFβ Activation. 2016 ·QJM ·Elaine Gower,(unknown),Valerie S. Morrison,Carmel B. Nanthakumar,(unknown)	2
12	Dissecting fibrosis: therapeutic insights from the small-molecule toolbox 2015 ·Nature Reviews Drug Discovery ·Carmel B. Nanthakumar,Richard J. D. Hatley,(unknown),Jack Gauldie,Richard P. Marshall,Simon J. F. Macdonald	173
13	mTOR signalling is an essential pathway for TGF-β₁induced collagen synthesis 2015 ·Hannah V. Woodcock,Simon Peace,Carmel B. Nanthakumar,Toby M. Maher,Paul F. Mercer,(unknown)	3
14	S136 Mtor Signalling Is An Essential Pathway For Tgf- 1 Induced sma And Collagen Gene Expression 2014 ·Thorax ·Hannah V. Woodcock,Simon Peace,Carmel B. Nanthakumar,Toby M. Maher,Paul F. Mercer,Rachel C. Chambers	2
15	Severity of Lung Injury in Cyclooxygenase-2-Deficient Mice Is Dependent on Reduced Prostaglandin E2 Production 2004 ·American Journal Of Pathology ·(unknown),Gísli Jenkins,Caroline Wheeler‐Jones,(unknown),Stephen E. Bottoms,Geoffrey Bellingan,Carmel B. Nanthakumar,Geoffrey J. Laurent,Stephen L. Hart,Martyn Foster,Robin J. McAnulty	108

About Carmel B. Nanthakumar

Carmel B. Nanthakumar is a scholar working on Pulmonary and Respiratory Medicine, Immunology and Allergy and Hepatology, having authored 15 papers that have together received 932 indexed citations. Recurring topics across this work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (11 papers), Inhalation and Respiratory Drug Delivery (4 papers) and Occupational exposure and asthma (3 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (604 citations), Immunology and Allergy (29 citations) and Hepatology (36 citations). Carmel B. Nanthakumar has collaborated with scholars based in United Kingdom, Denmark and United States. Frequent co-authors include Richard P. Marshall, Gísli Jenkins, Richard J. D. Hatley, Simon J. F. Macdonald, Jack Gauldie, Rachel C. Chambers, Geoffrey J. Laurent, Robin J. McAnulty, Amanda L. Tatler and Andy Blanchard. Their work appears in journals such as SHILAP Revista de lepidopterología, Nature Reviews Drug Discovery and American Journal Of Pathology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact